Non-surgical periodontal therapy with and without subgingival minocycline administration in patients with poorly controlled type II diabetes: A randomized controlled clinical trial

Clinical Oral Investigations

Volumn 16, Issue 2, 2012, Pages 599-609

  Lin, Shih Jung ^a   Tu, Yu Kang ^b   Tsai, Shiow Chwen ^c   Lai, Shih Ming ^a   Lu, Hsein Kun ^d  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c UNIVERSITY OF TAIPEI   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

CRP; HbA1c; Minocycline; Root planning; sRAGE; Type II diabetes

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; GLYCOSYLATED HEMOGLOBIN; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 6; MINOCYCLINE;

ADULT; AGED; ARTICLE; BLOOD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GINGIVA BLEEDING; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PERIODONTAL POCKET; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; DENTAL PLAQUE INDEX; DENTAL SCALING; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GINGIVAL HEMORRHAGE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MINOCYCLINE; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PERIODONTAL POCKET; RECEPTORS, IMMUNOLOGIC; ROOT PLANING;

EID: 84858796365     PISSN: 14326981     EISSN: 14363771     Source Type: Journal    
DOI: 10.1007/s00784-011-0535-x     Document Type: Article

References (50)

1. Mealey B, Ocampo G (2007) Diabetes mellitus and periodontal diseases. Periodontol 2000 44: 127-153.
2. Mealey BL, Oates TW (2006) Diabetes mellitus and periodontal diseases. J Periodontol 77: 1289-1303.
3. Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G (2005) Diabetes and periodontal disease: a case-control study. J Periodontol 76: 418-425.
4. Iwamoto Y, Nishimura F, Nakagawa M (2001) The effect of antimicrobial periodontal treatment on circulating TNF-α and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 72: 748-774.
5. Kirkwood K, Cirelli J, Rogers J, Giannobile W (2007) Novel host response therapeutic approaches to treat periodontal diseases. Periodontol 2000 43: 294-315.
6. Lu HK, Yang PC (2004) Cross-sectional analysis of different variables of patients with non-insulin dependent diabetes and their periodontal status. Int J Periodontics Restor Dent 24: 71-79.
7. Nelson RG, Shlossman M, Budding LM et al (1990) Periodontal disease and NIDDM in Pima Indians. Diab Care 13: 836-840.
8. Syrjala A-MH, Ylostalo P, Niskanen MC, Knuuttila MLE (2003) Role of smoking and HbA1c level in periodontitis among insulin-dependent diabetic patients. J Clin Periodontol 30: 871-875.
9. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M (1998) Glycemic control and alveolar bone loss progression in type 2 diabetes. Ann Periodontol 3: 30-39.
10. Taylor GW (2001) Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Ann Periodontol 6(1): 99-112.
11. Taylor GW, Burt BA, Becker MP et al (1996) Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 67: 1085-1093.
12. Graves D (2008) Cytokines that promote periodontal tissue destruction. J Periodontol 79: 1585-1591.
13. King G (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79: 1527-1534.
14. Nassar H, Kantarci A, van Dyke T (2007) Diabetic periodontitis: a model for activated innate immunity and impaired resolution of inflammation. Periodontol 2000 43: 233-244.
15. Nishimura F, Iwamoto Y, Mineshiba J, Shimizu A, Soga Y, Murayama Y (2003) Periodontal disease and diabetes mellitus: the role of tumor necrosis factor-α in a 2-way relationship. J Periodontol 74: 97-102.
16. Lin SJ, Chen YL, Kuo YB, Li CL, Lu HK (2005) Measurement of gp130 cytokines: oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 30: 160-167.
17. Katz J, Bhattacharyya I, Farkhondeh-Kish F et al (2005) Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR. J Clin Periodontol 32: 40-44.
18. Lalla E, Kaplan S, Yang J et al (2007) Effects of periodontal therapy on serum c-reactive protein, sE-selectin, and tumor necrosis factor-a secretion by peripheral blood-derived macrophages in diabetes. A pilot study. J Periodontal Res 42: 274-282.
19. Nakamura K, Yamagishi S, Adachi H et al (2007) Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 13: 185-189.
20. Nakamura K, Yamagishi S, Adachi H et al (2008) Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes. Microvasc Res 76: 52-56.
21. Janket SJ, Wightman A, Baird AE, van Dyke TE, Jones JA (2005) Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 84: 1154-1159.
22. Christgau M, Palitzsch K-D, Sclimah G, Kreiner U, Frenzel S (1998) Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. J Clin Periodontol 25: 112-124.
23. Jones J, Miller D, Wehler C et al (2007) Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study. J Clin Periodontol 34: 46-52.
24. Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A (2007) Effect of non-surgical periodontal therapy on clinical and immunological response and glycogenic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 34: 835-843.
25. Tervonen T, Lamminsalo S, Hiltunen L, Raunio T, Knuuttila M (2009) Resolution of periodontal inflammation does not guarantee improved glycemic control in type 1 diabetic subjects. J Clin Periodontol 36: 51-57.
26. Lu HK, Chei CJ (2005) Efficacy of subgingivally applied minocycline in the treatment of chronic periodontitis. J Periodontal Res 40: 20-27.
27. Grossi SG, Skrepcinski FB, DeCaro T et al (1997) Therapy of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 68: 713-719.
28. de Lima AF Martorelli, Cury CC, Palioto DB, Duro AM, da Silva RC, Wolff LF (2004) Therapy with adjunctive doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. J Clin Periodontol 31(8): 648-653.
29. O'Leary TJ, Drake RB, Naylor JE (1972) The plaque control record. J Periodontol 43: 38.
30. Bollen KA, Curran PJ (2006) Latent curve models. Wiley, Hoboken.
31. Duncan TE, Duncan SC, Strycker LA (2006) An introduction to latent variable growth curve modeling, 2nd edn. Laurence Erlbaum, Mahwah.
32. Tu YK, D'Aiuto F, Baelum V, Gilthorpe MS (2009) An introduction to latent growth curve modelling for longitudinal continuous data in dental research. Eur J Oral Sci 117: 343-350.
33. Hox J (2002) Multilevel analysis. Laurence Erlbaum, Mahwah.
34. Steele F (2008) Multilevel models for longitudinal data. J R Stat Soc A 171: 1-15.
35. Tu YK, Jackson M, Kellett M, Clerehugh V (2008) Direct and indirect effects of interdental hygiene in a clinical trial. J Dent Res 87: 1037-1042.
36. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J (1996) The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 23: 92-100.
37. Tervonen T, Karjalainen K (1997) Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 24: 505-510.
38. Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M (2009) Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol 80(10): 1574-1580.
39. Graves DT, Liu R, Oates TW (2007) Diabetes-enhanced inflammation and apoptosis-impact on periodontal pathosis. Periodontol 2000 45: 128-137.
40. Freeman DJ, Norrie J, Caslake MJ et al (2002) C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51: 1596-1600.
41. Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25: 4-7.
42. D'Aiuto F, Parkar M, Nibali L et al (2006) Periodontal infections cause changes in traditional and novel cardiovascular risk factors: results from a randomized controlled clinical trial. Am Heart J 151: 977-998.
43. Bahceci M, Tuzcu A, Ogun C et al (2005) Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in type 2 diabetic men with or without coronary heart disease? J Endocrinol Investig 28: 145-150.
44. Rodrigues D, Taba M, Novaes A, Souza S, Grisi M (2003) Effect of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes mellitus. J Periodontol 74: 1361-1367.
45. Schmidt AM, Hori O, Chen JX et al (1995) Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96: 1395-1403.
46. Schmidt AM, Yan SD, Wautier JL, Stern D (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 84: 489-497.
47. Lalla E, Lamster IB, Feit M et al (2000) Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 105(8): 1117-1124.
48. Hanford LE, Enghild JJ, Valnickova Z et al (2004) Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279: 50019-50024.
49. Vazzana N, Santilli F, Cuccurullo C, Davì G (2009) Soluble forms of RAGE in internal medicine. Intern Emerg Med 4: 389-401.
50. Goova MT, Li J, Kislinger T et al (2001) Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159: 513-525.